Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A patent review of topoisomerase I inhibitors (2016 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 29, 2021 Category: Drugs & Pharmacology Authors: Asier Selas Endika Martin-Encinas Maria Fuertes Carme Masdeu Gloria Rubiales Francisco Palacios Concepci ón Alonso Source Type: research

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 21, 2021 Category: Drugs & Pharmacology Authors: Austin N. Spratt Fabio Gallazzi Thomas P. Quinn Christian L. Lorson Anders S önnerborg Kamal Singh Source Type: research

Steroid sulfatase inhibitors: the current landscape
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 19, 2021 Category: Drugs & Pharmacology Authors: Hanan S. Anbar Zahraa Isa Jana J. Elounais Mariam A. Jameel Joudi H. Zib Aya M. Samer Aya F. Jawad Mohammed I. El-Gamal Source Type: research

Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 19, 2021 Category: Drugs & Pharmacology Authors: Tayo A. Adekiya Pradeep Kumar Pierre P.D. Kondiah Viness Pillay Yahya E. Choonara Source Type: research

Patent landscape of pediatric-friendly oral dosage forms and administration devices
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 19, 2021 Category: Drugs & Pharmacology Authors: Christina Karavasili Angelos Gkaragkounis Dimitrios G. Fatouros Source Type: research

Inhibitors of prostate-specific membrane antigen in the diagnosis and therapy of metastatic prostate cancer – a review of patent literature
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 16, 2021 Category: Drugs & Pharmacology Authors: Hyunsoo Ha Hongmok Kwon Taehyeong Lim Jaebong Jang Song-Kyu Park Youngjoo Byun Source Type: research

Aurora kinase inhibitors: a patent review (2014-2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 13, 2021 Category: Drugs & Pharmacology Authors: Xue-Li Jing Shi-Wu Chen Source Type: research

Synthetic molecules as DprE1 inhibitors: A patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 13, 2021 Category: Drugs & Pharmacology Authors: Mohd. Imran Alshrari A.S. Hamdy Kh. Thabet Abida Md. Afroz Bakht Source Type: research

Negative allosteric modulators of group II metabotropic glutamate receptors: A patent review (2015 – present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 31, 2021 Category: Drugs & Pharmacology Authors: Alshaima ’a M. Qunies Kyle A. Emmitte Source Type: research

Recent progress in small molecule TBK1 inhibitors: a patent review (2015 – 2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 31, 2021 Category: Drugs & Pharmacology Authors: Douglas W. Thomson Giovanna Bergamini Source Type: research

Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method: a patent evaluation of US2019202998A1
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 30, 2021 Category: Drugs & Pharmacology Authors: Thashree Marimuthu Pradeep Kumar Yahya E. Choonara Source Type: research

Coronaviruses
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 30, 2021 Category: Drugs & Pharmacology Authors: Claudiu T. Supuran Source Type: research

Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015 –2020
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 29, 2021 Category: Drugs & Pharmacology Authors: Quentin Spillier Rapha ël Frédérick Source Type: research

TRPV4 antagonists: a patent review (2015 –2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 24, 2021 Category: Drugs & Pharmacology Authors: Brian G. Lawhorn Edward J. Brnardic David J. Behm Source Type: research

Thioredoxin reductase inhibitors: updated patent review (2017-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - March 22, 2021 Category: Drugs & Pharmacology Authors: Evgeny Chupakhin Mikhail Krasavin Source Type: research